this post was submitted on 02 Apr 2024
71 points (91.8% liked)

Piracy: ꜱᴀɪʟ ᴛʜᴇ ʜɪɢʜ ꜱᴇᴀꜱ

54627 readers
484 users here now

⚓ Dedicated to the discussion of digital piracy, including ethical problems and legal advancements.

Rules • Full Version

1. Posts must be related to the discussion of digital piracy

2. Don't request invites, trade, sell, or self-promote

3. Don't request or link to specific pirated titles, including DMs

4. Don't submit low-quality posts, be entitled, or harass others



Loot, Pillage, & Plunder

📜 c/Piracy Wiki (Community Edition):


💰 Please help cover server costs.

Ko-Fi Liberapay
Ko-fi Liberapay

founded 1 year ago
MODERATORS
 

cross-posted from: https://mander.xyz/post/11304633

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

you are viewing a single comment's thread
view the rest of the comments
[–] 0xvalentin@lemmy.sdf.org -1 points 7 months ago (2 children)

I read the article and I don't think it factors in the upfront cost of R&D, Compliance, etc, so that's basically a fantasy number.

[–] seriousconsideration@lemmy.dbzer0.com 3 points 7 months ago* (last edited 7 months ago)

You're probably right. It's more than likely the cost per dose. Which is also what the $1000 figure represents.

The Vermont independent (Bernie) called on Novo Nordisk to lower the list price of Ozempic to $155 a month or less, in line with what it charges in other countries.

Somehow they can justify selling it for $155 a dose (per month?) in other countries while still making a profit above the overhead and compliance costs.

[–] Banzai51@midwest.social 3 points 7 months ago

Those are the costs of doing business, and can be greatly exaggerated. And other counties produce profitable drugs even with price restrictions. We're so accustomed to price gouging, that we don't recognize it.